Genome-wide analysis of noncoding regulatory mutations in cancer

Weinhold, Nils, Jacobsen, Anders, Schultz, Nikolaus, Sander, Chris, Lee, William·2014·Nature Genetics

Cited by (486)

Items 301–400 of 486

  1. The present and future of genome editing in cancer research
    Xiaoyi Li, Riga Wu, Andrea Ventura · 2016 · Human Genetics
  2. Identification of potential regulatory mutations using multi-omics analysis and haplotyping of lung adenocarcinoma cell lines
    Sarun Sereewattanawoot, Ayako Suzuki, Masahide Seki, Yoshitaka Sakamoto, Takashi Kohno, Sumio Sugano, Katsuya Tsuchihara, Yutaka Suzuki · 2018 · Scientific Reports
  3. Clinical Implications of Noncoding Indels in the Surfactant-Encoding Genes in Lung Cancer
    Takahiro Nakagomi, Yosuke Hirotsu, Taichiro Goto, Daichi Shikata, Yujiro Yokoyama, Rumi Higuchi, Sotaro Ohtake, Kenji Amemiya, Toshio Oyama, Hitoshi Mochizuki et al. · 2018 · Cancers
  4. Pathogenic noncoding variants in the neurofibromatosis and schwannomatosis predisposition genes
    Cristina Perez‐Becerril, D. Gareth Evans, Miriam Jane Smith · 2021 · Human Mutation
  5. Theranostic Interpolation of Genomic Instability in Breast Cancer
    Rabia Rasool, Inam Ullah, Bismillah Mubeen, Sultan Alshehri, Syed Sarim Imam, Mohammed M. Ghoneim, Sami Ibrahim Alzarea, Fahad Ahmed Al-Abbasi, Bibi Nazia Murtaza, Imran Ahmed Kazmi et al. · 2022 · International Journal of Molecular Sciences
  6. Integrating whole genome sequencing, methylation, gene expression, topologically associated domain information in regulatory mutation prediction: A study of follicular lymphoma
    Amna Farooq, Gunhild Trøen, Jan Delabie, Junbai Wang · 2022 · Computational and Structural Biotechnology Journal
  7. Tissue-specific impact of stem-loops and quadruplexes on cancer breakpoints formation
    Kseniia Cheloshkina, Maria S. Poptsova · 2019 · BMC Cancer
  8. Model for breast cancer diversity and spatial heterogeneity
    J. Roberto Romero-Arias, Guillermo Ramı́rez-Santiago, Jorge X. Velasco‐Hernández, Laurel Ohm, Maribel Hernández-Rosales · 2018 · Physical review. E
  9. Non-Coding Mutations in Urothelial Bladder Cancer: Biological and Clinical Relevance and Potential Utility as Biomarkers
    Alexander Yang, Christopher N. Cross, Jeffrey P. Townsend · 2020 · Bladder Cancer
  10. Mutational processes in cancer preferentially affect binding of particular transcription factors
    Mo Liu, Arnoud Boot, Alvin Wei Tian Ng, Raluca Gordân, Steve Rozen · 2021 · Scientific Reports
  11. The Identification and Interpretation of cis-Regulatory Noncoding Mutations in Cancer
    Minal B. Patel, Jun Wang · 2018 · Microarrays
  12. Estimating the Frequency of Single Point Driver Mutations across Common Solid Tumours
    Madeleine Darbyshire, Zachary D. du Toit, Mark F. Rogers, Tom R. Gaunt, Colin Campbell · 2019 · Scientific Reports
  13. Cancer regulatory variation
    Rebecca C. Hennessey, Kevin M Brown · 2021 · Current Opinion in Genetics & Development
  14. Pan-cancer analysis of non-coding recurrent mutations and their possible involvement in cancer pathogenesis
    Chie Kikutake, Minako Yoshihara, Mikita Suyama · 2021 · NAR Cancer
  15. SBSA: an online service for somatic binding sequence annotation
    Limin Jiang, Fei Guo, Jijun Tang, Hui Yu, Scott A. Ness, Mingrui Duan, Peng Mao, Ying‐Yong Zhao, Yan Ping Guo · 2021 · Nucleic Acids Research
  16. Key Members of the CmPn as Biomarkers Distinguish Histological and Immune Subtypes of Hepatic Cancers
    Johnathan Abou‐Fadel, Victoria A. Reid, Alexander Le, Jacob Croft, Jun Zhang · 2023 · Diagnostics
  17. iRegNet3D: three-dimensional integrated regulatory network for the genomic analysis of coding and non-coding disease mutations
    Siqi Liang, Nathaniel D. Tippens, Zhou Yaoda, Matthew E. Mort, Peter D. Stenson, D.N. Cooper, Haiyuan Yu · 2017 · Genome biology
  18. ncdDetect2: improved models of the site-specific mutation rate in cancer and driver detection with robust significance evaluation
    Malene Juul, Tobias Lynge Madsen, Qianyun Guo, Johanna Bertl, Asger Hobolth, M Kellis, Jakob Skou Pedersen · 2018 · Bioinformatics
  19. Deciphering the Gene Regulatory Landscape Encoded in DNA Biophysical Features
    Abhijeet Pataskar, Willem Vanderlinden, Johannes Emmerig, Aditi Puri Singh, Jan Lipfert, Vijay Kumar Tiwari · 2019 · iScience
  20. Motif-Raptor: a cell type-specific and transcription factor centric approach for post-GWAS prioritization of causal regulators
    Qiuming Yao, Paolo Ferragina, Yakir Reshef, Guillaume Lettre, Daniel E. Bauer, Luca Pinello · 2021 · Bioinformatics
  21. Quantifying Intensities of Transcription Factor-DNA Binding by Learning From an Ensemble of Protein Binding Microarrays
    Lijun Quan, Jie Mei, Ruji He, Xiaoyu Sun, Liangpeng Nie, Kailong Li, Qiang Lyu · 2021 · IEEE Journal of Biomedical and Health Informatics
  22. Heterozygotic Brca1 mutation initiates mouse genome instability at embryonic stage
    Xiaobing Wu, Maoni Guo, Jian Cui, Haoyang Cai, San Ming Wang · 2022 · Oncogenesis
  23. CrypticProteinDB: an integrated database of proteome and immunopeptidome derived non-canonical cancer proteins
    Ghofran Othoum, Christopher A. Maher · 2023 · NAR Cancer
  24. Identification of whole-genome mutations and structural variations of bile cell-free DNA in cholangiocarcinoma
    Lei Yin, Anqi Duan, Wei Zhang, Bin Li, Teng Zhao, Xiaoya Xu, Lixue Yang, Baoning Nian, Kai Lu, Sheng Chen et al. · 2024 · Genomics
  25. Frequency and Nature of Genomic Alterations in ERBB2-Altered Urothelial Bladder Cancer
    Jacob B. Leary, Thomas J. Enright, Dimitra Rafailia Bakaloudi, Alina Basnet, Gennady Bratslavsky, Joseph M Jacob, Philippe E. Spiess, Roger Li, Andrea Necchi, Ashish M. Kamat et al. · 2024 · Targeted Oncology
  26. Non-coding single nucleotide variants affecting estrogen receptor binding and activity
    Amir Bahreini, Kevin M. Levine, Lucas Santana‐Santos, Panayiotis V. Benos, Peilu Wang, Courtney L. Andersen, Steffi Oesterreich, Adrian V. Lee · 2016 · Genome Medicine
  27. MutEnricher: a flexible toolset for somatic mutation enrichment analysis of tumor whole genomes
    Anthony R. Soltis, Clifton L. Dalgard, Harvey B. Pollard, Matthew D. Wilkerson · 2020 · BMC Bioinformatics
  28. Cis-regulatory mutations with driver hallmarks in major cancers
    Zhongshan Cheng, Michael Vermeulen, Micheal Rollins-Green, Brian DeVeale, Tomas Babak · 2021 · iScience
  29. Pan‐cancer analysis of mutations in open chromatin regions and their possible association with cancer pathogenesis
    Chie Kikutake, Mikita Suyama · 2022 · Cancer Medicine
  30. SFPQ promotes RAS-mutant cancer cell growth by modulating 5′-UTR mediated translational control of CK1α
    Venetia Jing Tong Kok, Jia Ying Tang, Gracie Wee Ling Eng, Shin Yi Tan, Joseph Tin Foong Chin, Chun Hian Quek, Wei Xuan Lai, Teck Kwang Lim, Qingsong Lin, John Jia En Chua et al. · 2022 · NAR Cancer
  31. Evolution of Multiple Myeloma from a Genomic Perspective
    Maura, Francesco, Samur, Mehmet, Munshi, Nikhil · 2026 · Blood
  32. Germline Non-CDKN2A Variants in Melanoma and Associated Hereditary Cancer Syndromes
    Chiara Anna Fiasconaro, Alice Carbone, Silvia Giordano, Francesco Cavallo, Paolo Fava, Barbara Pasini, Yuliya Yakymiv, Sara Marchisio, Pietro Quaglino, Simone Ribero et al. · 2025 · Diseases
  33. A compendium of next-generation patient-derived models for diverse cancers
    Dina ElHarouni, Mushriq Al‐Jazrawe, Seongmin Choi, Merve Dede, Toshinori Hinoue, Sean A. Misek, Heeju Noh, Luca Zanella, Yuen-Yi Tseng, Hayley E. Francies et al. · 2026 · Nature
  34. Network perturbation by recurrent regulatory variants in cancer
    Kiwon Jang, Kwoneel Kim, Ara Cho, Insuk Lee, Jung Kyoon Choi · 2017 · PLoS Computational Biology
  35. Applications of ENCODE data to systematic analyses via data integration
    Yanding Zhao, Evelien Schaafsma, Chao Cheng · 2018 · Current Opinion in Systems Biology
  36. In vitro germ cell induction from fertile and infertile monozygotic twin research participants
    Erica C. Pandolfi, Fei‐Man Hsu, Mark Duhon, Yi Zheng, Sierra Goldsmith, Jianping Fu, Sherman J. Silber, Amander T. Clark · 2022 · Cell Reports Medicine
  37. Sequence of events in prostate cancer
    Kellie A. Cotter, Mark A. Rubin · 2018 · Nature
  38. Robustness and Evolvability in Transcriptional Regulation
    José Aguilar-Rodríguez, Joshua L. Payne · 2021 · Springer eBooks
  39. Genomic landscape of a mouse model of diffuse-type gastric adenocarcinoma
    Menghua Zhang, Itsuki Sugita, Daisuke Komura, Hiroto Katoh, Shu Shimada, Johji Inazawa, Shinji Tanaka, Shumpei Ishikawa · 2021 · Gastric Cancer
  40. The Genome in a Three-Dimensional Context: Deciphering the Contribution of Noncoding Mutations at Enhancers to Blood Cancer
    Llorenç Rovirosa, Alberto Ramos-Morales, Biola M. Javierre · 2020 · Frontiers in Immunology
  41. SMDB: pivotal somatic sequence alterations reprogramming regulatory cascades
    Limin Jiang, Mingrui Duan, Fei Guo, Jijun Tang, Olufunmilola Oyebamiji, Hui Yu, Scott A. Ness, Ying‐Yong Zhao, Peng Mao, Yan Ping Guo · 2020 · NAR Cancer
  42. DriverGroup : a novel method for identifying driver gene groups
    Vu Pham, Lin Liu, Cameron P. Bracken, Gregory J. Goodall, Jiuyong Li, Thuc Duy Le · 2020 · Bioinformatics
  43. BayesPI-BAR2: A New Python Package for Predicting Functional Non-coding Mutations in Cancer Patient Cohorts
    Kirill Batmanov, Jan Delabie, Junbai Wang · 2019 · Frontiers in Genetics
  44. Non-B DNA structures and their contributions to genetic diversity, aging, and disease
    Eleftherios Bochalis, Irene Dereki, Guliang Wang, Argyro Sgourou, Karen M. Vásquez, Ilias Georgakopoulos‐Soares · 2026 · Nucleic Acids Research
  45. Scarcity of Recurrent Regulatory Driver Mutations in Colorectal Cancer Revealed by Targeted Deep Sequencing
    Rebecca C. Poulos, D. S. Perera, Deborah Packham, Anushi Shah, Caroline Janitz, John E. Pimanda, Nicholas John Hawkins, Robyn Lynne Ward, Luke B. Hesson, Jason W.H. Wong · 2019 · JNCI Cancer Spectrum
  46. Functional annotation of noncoding mutations in cancer
    Husen Muhammad Umer, Karolina Smolińska, Jan Komorowski, Claes Wadelius · 2021 · Life Science Alliance
  47. Clinical and pathological characteristics of familial melanoma with germline TERT promoter variants
    Anne Zaremba, Friedegund Elke Meier, Christian Schlein, Philipp Jansen, Georg Christian Lodde, Mingxia Song, Julia Kretz, Inga Möller, Nadine Stadtler, Elisabeth Livingstone et al. · 2022 · Pigment Cell & Melanoma Research
  48. Model selection and robust inference of mutational signatures using Negative Binomial non-negative matrix factorization
    Marta Pelizzola, Ragnhild Laursen, A. Hobolth · 2022 · BMC Bioinformatics
  49. Identifying functional regulatory mutation blocks by integrating genome sequencing and transcriptome data
    Mingyi Yang, Omer Ali, Magnar Bjørås, Junbai Wang · 2023 · iScience
  50. Determinants of gastric cancer immune escape identified from non-coding immune-landscape quantitative trait loci
    Christos Miliotis, Yuling Ma, Xanthi-Lida Katopodi, Dimitra Karagkouni, Eleni Kanata, Kaia Mattioli, Nikolaos Kalavros, Yered H. Pita-Juárez, Felipe Batalini, Varune Rohan Ramnarine et al. · 2024 · Nature Communications
  51. Allelic mutations in noncoding genomic sequences construct novel transcription factor binding sites that promote gene overexpression
    Erming Tian, Magne Børset, Jeffrey R. Sawyer, Gaute Brede, Thea Kristin Våtsveen, Håkon Hov, Anders Waage, Bart Barlogie, John D. Shaughnessy, Joshua Epstein et al. · 2015 · Genes Chromosomes and Cancer
  52. Defects of the Carney complex gene (PRKAR1A) in odontogenic tumors
    Sílvia Ferreira de Sousa, Ricardo Santiago Gomez, Marina Gonçalves Diniz, Vanessa Fátima Bernardes, Flávia Fonseca Carvalho Soares, João Artur Ricieri Brito, Sophie N. Liu, Hélder Antônio Rebelo Pontes, Constantine A. Stratakis, Carolina Cavaliéri Gomes · 2015 · Endocrine Related Cancer
  53. Altérations moléculaires au cours de la carcinogenèse urothéliale vésicale
    G. Pignot, Constance le Goux, Ivan Bièche · 2015 · Bulletin du Cancer
  54. Quantitative Trait Loci Identify Functional Noncoding Variation in Cancer
    Holger Heyn · 2016 · PLoS Genetics
  55. Genetic diagnosis of a Chinese multiple endocrine neoplasia type 2A family through whole genome sequencing
    Zhenfang Du, Pengfei Li, Jian‐Qiang Zhao, Zhi-Lie Cao, Feng Li, Juming Ma, Xiao-Ping Qi · 2017 · Journal of Biosciences
  56. NIMBus: a negative binomial regression based Integrative Method for mutation Burden Analysis
    Jing Zhang, Jason J. Liu, Patrick D. McGillivray, Caroline Yi, Lucas Lochovsky, Donghoon Lee, Mark Gerstein · 2020 · BMC Bioinformatics
  57. Integrative identification of non-coding regulatory regions driving metastatic prostate cancer
    Brian J. Woo, Ruhollah Moussavi-Baygi, Heather M. Karner, Mehran Karimzadeh, Hassan Yousefi, Sean M. Lee, Kristle Garcia, Tanvi V. Joshi, Keyi Yin, Albertas Navickas et al. · 2024 · Cell Reports
  58. Using evolutionary constraint to define novel candidate driver genes in medulloblastoma
    Ananya Roy, Sharadha Sakthikumar, Sergey V. Kozyrev, Jessika Nordin, Raphaela Pensch, Suvi Mäkeläinen, Mats E. Pettersson, Elinor K. Karlsson, Kerstin Lindblad‐Toh, Karin Forsberg‐Nilsson et al. · 2023 · Proceedings of the National Academy of Sciences
  59. Genome stability: An evolutionary perspective
    Igor Kovalchuk · 2021 · Elsevier eBooks
  60. Intrinsic Molecular Processes: Impact on Mutagenesis
    Byungho Lim, Jihyeob Mun, Seon‐Young Kim · 2017 · Trends in cancer
  61. Novel Mutation Hotspots within Non-Coding Regulatory Regions of the Chronic Lymphocytic Leukemia Genome
    Adrián Mosquera Orgueira, Beatriz Antelo Rodríguez, José Ángel Díaz Arias, Nicolas A Diaz Varela, Natalia Alonso Vence, Marta Sonia González, Jose Luís Bello López · 2020 · Scientific Reports
  62. A comprehensive analysis of cancer-driving mutations and genes in kidney cancer
    Chengmei Long, Jinbo Jian, Xinchang Li, Gongxian Wang, Jingen Wang · 2017 · Oncology Letters
  63. Massively parallel sequencing of urinary DNA—the dawn of non-invasive bladder cancer detection and surveillance?
    Douglas G. Ward, Richard T. Bryan · 2019 · Translational Cancer Research
  64. Association of a single amino acid replacement with dorsal pigmentation in a lizard from the Qinghai-Tibetan Plateau
    Haojie Tong, Gang Qin Shao, Leijie Wang, Jiasheng Li, Tao Wang, Lun Zhang, Yudie Lv, Fei Ye, Caiyun Fu, Yuanting Jin · 2023 · International Journal of Biological Macromolecules
  65. XLR-Net: Explainable AI-driven improved L 1 -regularized deep neural architecture for NSCLC biomarker identification
    Kountay Dwivedi, Ankit Rajpal, Sheetal Rajpal, Virendra Kumar, Manoj Agarwal, Naveen Kumar · 2023 · Computational Biology and Chemistry
  66. HATZFS predicts pancreatic cancer driver biomarkers by hierarchical reinforcement learning and zero-forcing set
    Jie Hong, Wenju Hou, Nan Sheng, Chunman Zuo, Yan Wang · 2024 · Expert Systems with Applications
  67. Melanoma-specific mutation hotspots in distal, non-coding, promoter-interacting regions implicate novel candidate driver genes
    Michael Pudjihartono, Nicholas Pudjihartono, Justin Martin O'Sullivan, William S. Schierding · 2024 · British Journal of Cancer
  68. Germline mutations predisposing to melanoma and associated malignancies and syndromes: a narrative review
    Irene López Riquelme, Silvestre Martínez García, Ana Serrano Ordóñez, Leandro Martínez Pilar · 2024 · International Journal of Dermatology
  69. TELS: A Novel Computational Framework for Identifying Motif Signatures of Transcribed Enhancers
    Dimitrios Kleftogiannis, Haitham Ashoor, Nikolaos Zarokanellos, Vladimir B. Bajić · 2018 · Genomics Proteomics & Bioinformatics
  70. Deciphering the Functions of Telomerase Reverse Transcriptase in Head and Neck Cancer
    Tsung‐Jang Yeh, Chi‐Wen Luo, Jeng‐Shiun Du, Chien-Tzu Huang, Min-Hung Wang, Benjamin Tzer-Ming Chuang, Yuh‐Ching Gau, Shih‐Feng Cho, Yi‐Chang Liu, Hui‐Hua Hsiao et al. · 2023 · Biomedicines
  71. SMuRF: a novel tool to identify regulatory elements enriched for somatic point mutations
    Paul Guilhamon, Mathieu Lupien · 2018 · BMC Bioinformatics
  72. Untangling a complex web: Computational analyses of tumor molecular profiles to decode driver mechanisms
    Sirvan Khalighi, Salendra Singh, Vinay Varadan · 2020 · Journal of genetics and genomics/Journal of Genetics and Genomics
  73. Two ovarian candidate enhancers, identified by time series enhancer RNA analyses, harbor rare genetic variations identified in ovarian insufficiency
    Ryuichi Nakagawa, Kei Takasawa, Maki Gau, Atsumi Tsuji‐Hosokawa, Hideya Kawaji, Yasuhiro Murakawa, Shuji Takada, Masashi Mikami, Satoshi Narumi, Maki Fukami et al. · 2022 · Human Molecular Genetics
  74. Whole-genome mutational analysis: cause and effect of noncoding and structural mutations in liver cancer
    Suchandrima Ghosh, Soma Banerjee · 2017 · HepatoBiliary Surgery and Nutrition
  75. Prevention of Urinary Bladder Cancer: The Interface Between Experimental and Human Studies.
    Shoji Fukushima, Hideki Wanibuchi · 2000 · PubMed
  76. Computational Prediction of Genetic Drivers in Cancer
    Alice B. S. Nono Djotsa, Ken Chen, Xiaoming Liu · 2016 · Encyclopedia of Life Sciences
  77. Non-canonical secondary structures arising from non-B-DNA motifs are determinants of mutagenesis
    Ilias Georgakopoulos‐Soares, Sandro Morganella, Naman Jain, Martin Hemberg, Serena Nik‐Zainal · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
  78. Comprehensive Characterization of Somatic Mutation Timing Reveals the Evolutionary Trajectory of Lung Adenocarcinoma in Chinese Patients
    Na Qin, Zhoufeng Wang, Xianfeng Xu, Yuan Xie, Yingjia Chen, Wenxin Luo, Pan Tang, Xin Wang, Lingfeng Bi, Linnan Gong et al. · 2025 · Cancer Research
  79. The Noncoding Mutational Landscape of Pancreatic Cancer Reveals Recurrent Somatic Mutations in Enhancer Regions
    Akimasa Hayashi, Yu-Jui Ho, Alvin P. Makohon-Moore, Amanda Zucker, Jungeui Hong, Shigeaki Umeda, Elias-Ramzey R. Karnoub, Jinlong Huang, Priscilla Baez, Rajya L. Kappagantula et al. · 2025 · Cancer Research Communications
  80. Liquid-liquid phase separation of ATXN2L enhances mRNA translation in hepatocellular carcinoma
    Shenghong Wang, Peilan Guo, Wenqiang Ma, Honglin Huang, Qianqian Zhang, Sławomir Wołczyński, Nafis Ahmed Rahman, Jiali Liu, Suk Ying Tsang, Xuguang Du et al. · 2025 · Cell Reports
  81. Loss of XRCC1 promotes cGAS/STING mediated innate immune signaling in gastric cancer
    Aashirwad Shahi, Shengyuan Zhao, Julia A. Goewey Ruiz, Dawit Kidane · 2026 · Molecular Medicine
  82. Prospective Identification of Prognostic Hot-Spot Mutant Gene Signatures for Leukemia: A Computational Study Based on Integrative Analysis of TCGA and cBioPortal Data
    Min Zhang, Xianghua Lang, Xinyi Chen, Yuke Lv · 2023 · Molecular Biotechnology
  83. Evaluation of vital genes correlated with CD8 + T cell infiltration as prognostic biomarkers in stomach adenocarcinoma
    Dun Pan, Hui Chen, Jiaxiang Xu, Xin Lin, Liangqing Li · 2023 · BMC Gastroenterology
  84. Cancer somatic mutations cluster in a subset of regulatory sites predicted from the ENCODE data
    Nisar Ahmed Shar, M. S. Vijayabaskar, David R. Westhead · 2016 · Molecular Cancer
  85. Circular RNAs and Untranslated Regions in Acute Myeloid Leukemia
    Shih-Chia Yeh, Faith J. F. Cheong, Yvonne Tay · 2023 · International Journal of Molecular Sciences
  86. Enhancer in cancer pathogenesis and treatment
    Zhuo Sun, Jinbo Fan, Yixiong Dang, Yufeng Zhao · 2023 · Genetics and Molecular Biology
  87. Leveraging Tissue-Specific Enhancer–Target Gene Regulatory Networks Identifies Enhancer Somatic Mutations That Functionally Impact Lung Cancer
    Judith Mary Hariprakash, Elisa Salviato, Federica La Mastra, Endre Sebestyén, Ilario Tagliaferri, Raquel Sofia Silva, Federica Lucini, Lorenzo Farina, Mario Cinquanta, Ilaria Rancati et al. · 2023 · Cancer Research
  88. Olovnikov, Telomeres, and Telomerase. Is It Possible to Prolong a Healthy Life?
    Yegor E. Yegorov · 2023 · Biochemistry (Moscow)
  89. Discriminative identification of transcriptional responses of promoters and enhancers after stimulus
    Dimitrios Kleftogiannis, Panos Kalnis, Erik Arner, Vladimir B. Bajić · 2016 · Nucleic Acids Research
  90. A functional strategy to characterize expression Quantitative Trait Loci
    Elena Grassi, Elisa Mariella, Mattia Forneris, Federico Marotta, Marika Catapano, Ivan Molineris, Paolo Provero · 2017 · Human Genetics
  91. Motif Disruption Domains Lead To Cancer Gene Expression Rewiring
    Fabien Claude Lamaze, Aurélien Chateigner, Hilary A. Edgington, Marie-Julie Favé, Armande Ang Houle, PCAWG3, Philip Awadalla · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
  92. A pan cancer analysis of promoter activity highlights the regulatory role of alternative transcription start sites and their association with noncoding mutations
    Deniz Demircioğlu, Martin Kindermans, Tannistha Nandi, Engin Cukuroglu, Claudia Calabrese, Nuno A. Fonseca, André Kahles, Kjong-Van Lehmann, Oliver Stegle, Pcawg et al. · 2017 · Repository for Publications and Research Data (ETH Zurich)
  93. Assessing the Gene Regulatory Landscape in 1,188 Human Tumors
    C. Calabrese, K. Lehmann, L. Urban, F. Liu, S. Erkek, NA Fonseca, A. Kahles, H. Kilpinen, J. Markowski, Sebastian M. Waszak et al. · 2017 · bioRxiv
  94. Evolutionary Dynamics of Non-Coding Regions in Pancreatic Ductal Adenocarcinoma
    Akimasa Hayashi, Yu-Jui Ho, Alvin P. Makohon-Moore, Amanda Zucker, Jungeui Hong, Johannes G. Reiter, Jinlong Huang, Lance Zhang, Marc A. Attiyeh, Priscilla Baez et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  95. Somatic Mutations and Risk-Variants Converge on Cis-Regulatory Elements to Reveal the Cancer Driver Transcription Regulators in Primary Prostate Tumors
    Parisa Mazrooei, Ken J. Kron, Yanyun Zhu, Tahmid Mehdi, Stanley Zhou, Musaddeque Ahmed, Tesa Severson, Paul Guilhamon, Nicholas Sinnott Armstrong, Vincent Huang et al. · 2018 · SSRN Electronic Journal
  96. Identification of Cholangiocarcinoma (CCA) Subtype-Specific Biomarkers
    Jacob Croft, Liyuan Gao, Odalys Quintanar, Victor S. Sheng, Jun Zhang · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  97. Noncoding variation near UBE2E2 orchestrates cardiometabolic pathophenotypes through polygenic effectors
    Yang Zhang, Natalie L. David, Tristan Pesaresi, Rosemary E. Andrews, G.V. Naveen Kumar, Hongyin Chen, Wanning Qiao, Jinzhao Yang, Kareena Patel, Tânia Amorim et al. · 2024 · JCI Insight
  98. Tumor protein 53 gene polymorphism, demographic attributes and associated risk factors among liver cancer patients in Calabar, Nigeria
    Blessing B Ekpenyong, Godwin Michael Ubi, MaryEsien Kooffreh, Anthony John Umoyen, Cecilia S James, Ivon A. Ettah, Nseabasi A. Etangetuk, Bassey Ekeng Effiom, Philip Abane Okpechi, Bassey James Ejue et al. · 2025 · BMC Cancer
  99. Genome‐wide analysis of somatic noncoding mutation patterns and mitochondrial heteroplasmic shift in type B1 and B2 thymomas
    Kohei Fujikura, Isabel Correa, Susanne Heck, Kaoru Watanabe, Juliet Elizabeth King, Emma McLean, Susan Ndagire, Yoshihisa Takahashi, Masahiko Kuroda, Andrea Billè et al. · 2025 · The Journal of Pathology
  100. Scanning window analysis of non-coding regions within normal-tumor whole-genome sequence samples
    John Torcivia-Rodriguez, Raja Mazumder · 2020 · Briefings in Bioinformatics